Longeviti Neuro Solutions has been tasked with advancing neurosurgery through the development of low-profile intracranial implants that address the functional and reconstructive needs of patients with neurological conditions. And the company has been busy lately.
Late last month, the Baltimore, MD-based firm received clearance from FDA of the ClearFit implant for use in ultrasound in post-operative imaging. And last week the company announced results of a study demonstrating that the InvisiShunt implant shows promising outcomes with a low complication rate for patients. Results were published in The Journal of Craniofacial Surgery.
Longeviti’s cofounder and CEO Jesse Christopher stopped by Let’s Talk Medtech to discuss the firm; its products; and being at the helm of a company during a pandemic.